State Street Corp Buys 995 Shares of Nutrien Ltd. (NYSE:NTR)

State Street Corp grew its stake in Nutrien Ltd. (NYSE:NTR) by 0.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,488,841 shares of the company’s stock after acquiring an additional 995 shares during the period. State Street Corp’s holdings in Nutrien were worth $120,961,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. Goodman Financial Corp grew its stake in Nutrien by 4.6% in the third quarter. Goodman Financial Corp now owns 253,860 shares of the company’s stock worth $12,201,000 after purchasing an additional 11,058 shares in the last quarter. CORDA Investment Management LLC. lifted its holdings in shares of Nutrien by 7.0% in the 3rd quarter. CORDA Investment Management LLC. now owns 494,745 shares of the company’s stock worth $23,777,000 after buying an additional 32,541 shares during the period. Charles Schwab Investment Management Inc. grew its position in shares of Nutrien by 10.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,742,351 shares of the company’s stock worth $83,812,000 after buying an additional 157,932 shares in the last quarter. Cardinal Capital Management Inc. increased its stake in shares of Nutrien by 4.3% during the third quarter. Cardinal Capital Management Inc. now owns 564,078 shares of the company’s stock valued at $27,139,000 after buying an additional 23,117 shares during the period. Finally, Stephens Inc. AR raised its holdings in shares of Nutrien by 335.0% in the third quarter. Stephens Inc. AR now owns 70,301 shares of the company’s stock valued at $3,379,000 after acquiring an additional 54,138 shares in the last quarter. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Trading Up 0.5 %

NYSE:NTR opened at $48.18 on Friday. The company has a market capitalization of $23.72 billion, a P/E ratio of 32.34, a PEG ratio of 1.72 and a beta of 0.80. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. Nutrien Ltd. has a 12 month low of $44.65 and a 12 month high of $60.87. The firm has a fifty day simple moving average of $47.85 and a 200-day simple moving average of $49.02.

Nutrien (NYSE:NTR) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). The firm had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business’s revenue was down 5.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.35 EPS. On average, equities research analysts anticipate that Nutrien Ltd. will post 3.49 earnings per share for the current year.

Nutrien Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 17th. Investors of record on Tuesday, December 31st will be issued a $0.939 dividend. This represents a $3.76 annualized dividend and a yield of 7.80%. The ex-dividend date of this dividend is Tuesday, December 31st. This is an increase from Nutrien’s previous quarterly dividend of $0.54. Nutrien’s dividend payout ratio is 144.97%.

Analyst Upgrades and Downgrades

NTR has been the topic of several recent research reports. Wells Fargo & Company cut shares of Nutrien from an “overweight” rating to an “equal weight” rating and dropped their target price for the stock from $62.00 to $50.00 in a report on Tuesday, September 24th. TD Securities cut their price objective on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a report on Tuesday, November 12th. Oppenheimer began coverage on Nutrien in a report on Thursday. They set an “outperform” rating and a $60.00 target price for the company. UBS Group downgraded Nutrien from a “buy” rating to a “neutral” rating and cut their price target for the company from $66.00 to $51.00 in a report on Thursday, October 10th. Finally, Raymond James raised Nutrien from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $58.00 to $60.00 in a research report on Tuesday, December 3rd. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $58.95.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.